Cargando…

Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis

BACKGROUND: Immunohistochemical studies of lymphatic vessels have been limited by a lack of specific markers. Recently, the novel D2-40 antibody, which selectively marks endothelium of lymphatic vessels, was released. The aim of our study is to compare lymphatic and blood vessel invasion detected by...

Descripción completa

Detalles Bibliográficos
Autores principales: Marinho, Vanessa FZ, Metze, Konradin, Sanches, Fernanda SF, Rocha, Gislene FS, Gobbi, Helenice
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2294134/
https://www.ncbi.nlm.nih.gov/pubmed/18307818
http://dx.doi.org/10.1186/1471-2407-8-64
_version_ 1782152542228054016
author Marinho, Vanessa FZ
Metze, Konradin
Sanches, Fernanda SF
Rocha, Gislene FS
Gobbi, Helenice
author_facet Marinho, Vanessa FZ
Metze, Konradin
Sanches, Fernanda SF
Rocha, Gislene FS
Gobbi, Helenice
author_sort Marinho, Vanessa FZ
collection PubMed
description BACKGROUND: Immunohistochemical studies of lymphatic vessels have been limited by a lack of specific markers. Recently, the novel D2-40 antibody, which selectively marks endothelium of lymphatic vessels, was released. The aim of our study is to compare lymphatic and blood vessel invasion detected by hematoxylin and eosin (H&E) versus that detected by immunohistochemistry, relating them with morphologic and molecular prognostic factors. METHODS: We selected 123 cases of invasive mammary carcinomas stratified into three subgroups according to axillary lymph node status: macrometastases, micrometastases, and lymph node negative. Lymphatic (LVI) and blood (BVI) vessel invasion were evaluated by H&E and immunohistochemistry using the D2-40 and CD31 antibodies, and related to histologic tumor type and grade, estrogen and progesterone receptors, E-cadherin, Ki67, p53, and Her2/neu expression. RESULTS: LVI was detected in H&E-stained sections in 17/123 cases (13.8%), and in D2-40 sections in 35/123 cases (28.5%) (Kappa = 0.433). BVI was detected in H&E-stained sections in 5/123 cases (4.1%), and in CD31 stained sections in 19/123 cases (15.4%) (Kappa = 0.198). LVI is positively related to higher histologic grade (p = 0.013), higher Ki67 expression (p = 0.00013), and to the presence of macrometastases (p = 0.002), and inversely related to estrogen (p = 0.0016) and progesterone (p = 0.00017) receptors expression. CONCLUSION: D2-40 is a reliable marker of lymphatic vessels and is a useful tool for lymphatic emboli identification in immunostained sections of breast carcinomas with higher identification rates than H&E. Lymphatic vessel invasion was related to other features (high combined histologic grade, high Ki67 score, negative hormone receptors expression) associated with worse prognosis, probable reflecting a potential for lymphatic metastatic spread and aggressive behavior.
format Text
id pubmed-2294134
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-22941342008-04-15 Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis Marinho, Vanessa FZ Metze, Konradin Sanches, Fernanda SF Rocha, Gislene FS Gobbi, Helenice BMC Cancer Research Article BACKGROUND: Immunohistochemical studies of lymphatic vessels have been limited by a lack of specific markers. Recently, the novel D2-40 antibody, which selectively marks endothelium of lymphatic vessels, was released. The aim of our study is to compare lymphatic and blood vessel invasion detected by hematoxylin and eosin (H&E) versus that detected by immunohistochemistry, relating them with morphologic and molecular prognostic factors. METHODS: We selected 123 cases of invasive mammary carcinomas stratified into three subgroups according to axillary lymph node status: macrometastases, micrometastases, and lymph node negative. Lymphatic (LVI) and blood (BVI) vessel invasion were evaluated by H&E and immunohistochemistry using the D2-40 and CD31 antibodies, and related to histologic tumor type and grade, estrogen and progesterone receptors, E-cadherin, Ki67, p53, and Her2/neu expression. RESULTS: LVI was detected in H&E-stained sections in 17/123 cases (13.8%), and in D2-40 sections in 35/123 cases (28.5%) (Kappa = 0.433). BVI was detected in H&E-stained sections in 5/123 cases (4.1%), and in CD31 stained sections in 19/123 cases (15.4%) (Kappa = 0.198). LVI is positively related to higher histologic grade (p = 0.013), higher Ki67 expression (p = 0.00013), and to the presence of macrometastases (p = 0.002), and inversely related to estrogen (p = 0.0016) and progesterone (p = 0.00017) receptors expression. CONCLUSION: D2-40 is a reliable marker of lymphatic vessels and is a useful tool for lymphatic emboli identification in immunostained sections of breast carcinomas with higher identification rates than H&E. Lymphatic vessel invasion was related to other features (high combined histologic grade, high Ki67 score, negative hormone receptors expression) associated with worse prognosis, probable reflecting a potential for lymphatic metastatic spread and aggressive behavior. BioMed Central 2008-02-29 /pmc/articles/PMC2294134/ /pubmed/18307818 http://dx.doi.org/10.1186/1471-2407-8-64 Text en Copyright © 2008 Marinho et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Marinho, Vanessa FZ
Metze, Konradin
Sanches, Fernanda SF
Rocha, Gislene FS
Gobbi, Helenice
Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis
title Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis
title_full Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis
title_fullStr Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis
title_full_unstemmed Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis
title_short Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis
title_sort lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker d2-40 is associated with other indicators of poor prognosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2294134/
https://www.ncbi.nlm.nih.gov/pubmed/18307818
http://dx.doi.org/10.1186/1471-2407-8-64
work_keys_str_mv AT marinhovanessafz lymphvascularinvasionininvasivemammarycarcinomasidentifiedbytheendotheliallymphaticmarkerd240isassociatedwithotherindicatorsofpoorprognosis
AT metzekonradin lymphvascularinvasionininvasivemammarycarcinomasidentifiedbytheendotheliallymphaticmarkerd240isassociatedwithotherindicatorsofpoorprognosis
AT sanchesfernandasf lymphvascularinvasionininvasivemammarycarcinomasidentifiedbytheendotheliallymphaticmarkerd240isassociatedwithotherindicatorsofpoorprognosis
AT rochagislenefs lymphvascularinvasionininvasivemammarycarcinomasidentifiedbytheendotheliallymphaticmarkerd240isassociatedwithotherindicatorsofpoorprognosis
AT gobbihelenice lymphvascularinvasionininvasivemammarycarcinomasidentifiedbytheendotheliallymphaticmarkerd240isassociatedwithotherindicatorsofpoorprognosis